ReviewMyocardial Infarction

Cell type–specific microRNA therapies for myocardial infarction

See allHide authors and affiliations

Science Translational Medicine  10 Feb 2021:
Vol. 13, Issue 580, eabd0914
DOI: 10.1126/scitranslmed.abd0914

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Abstract

Current interventions fail to recover injured myocardium after infarction and prompt the need for development of cardioprotective strategies. Of increasing interest is the therapeutic use of microRNAs to control gene expression through specific targeting of mRNAs. In this Review, we discuss current microRNA-based therapeutic strategies, describing the outcomes and limitations of key microRNAs with a focus on target cell types and molecular pathways. Last, we offer a perspective on the outlook of microRNA therapies for myocardial infarction, highlighting the outstanding challenges and emerging strategies.

View Full Text

Stay Connected to Science Translational Medicine